NCT05836623 2024-02-28A Phase I Study to Assess PSMA+ and PSMA- Tumour LesionsCrescendo Biologics Ltd.Phase 1 Unknown5 enrolled
NCT00369252 2007-02-28Phase I Study of Nimotuzumab in Solid TumoursYM BioSciencesPhase 1 Completed18 enrolled